VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
Conference call to take place on Tuesday May 14 at 8:30 a.m. U.S Eastern Time
電話會議將於美國東部時間5月14日星期二上午 8:30 舉行
HENDERSON, Nev., May 8, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, May 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the first quarter 2024, in addition to providing a business update. Details of this event can also be found below.
內華達州亨德森，2024年5月8日 /PRNewswire/ — VolitionRX Limited（美國紐約證券交易所代碼：VNRX）（“Volition”）今天宣佈，它將在美國東部時間5月14日星期二上午8點30分舉行電話會議，討論其2024年第一季度的財務和經營業績，並提供最新業務情況。此活動的詳細信息也可以在下面找到。
Event: VolitionRx Limited First Quarter 2024 Earnings and Business Update Conference Call
Date: Tuesday, May 14, 2024
Time: 8:30 a.m. U.S. Eastern Time
活動：VolitionRX Limited 2024年第一季度收益和業務更新電話會議
日期： 2024 年 5 月 14 日，星期二
時間： 美國東部時間上午 8:30
U.S. & Canada Dial-in:1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID:13746549
美國和加拿大撥號：1-877-407-9716（免費電話）
英國撥號： 0 800 756 3429（免費電話）
通行費/國際： 1-201-493-6779
會議編號：13746549
Louise Batchelor, Group Chief Marketing & Communications Officer will host the call along with Cameron Reynolds, President and Group Chief Executive Officer of Volition, Terig Hughes, Group Chief Financial Officer, Dr. Andrew Retter, Chief Medical Officer and Gael Forterre, Chief Commercial Officer. The call will provide an update on important events which have taken place in the first quarter of 2024 and upcoming milestones.
集團首席營銷與傳播官路易絲·巴切勒將與Volition總裁兼集團首席執行官卡梅隆·雷諾茲、集團首席財務官泰裏格·休斯、首席醫療官安德魯·雷特博士和首席商務官蓋爾·福特雷一起主持電話會議。該電話會議將提供2024年第一季度發生的重要事件和即將到來的里程碑的最新情況。
A live audio webcast of the conference call will also be available on the investor relations page of Volition's corporate website at In addition, a telephone replay of the call will be available until May 28, 2024. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13746549.
電話會議的網絡直播還將在Volition公司網站的投資者關係頁面上播出。此外，電話會議的電話重播將持續到2024年5月28日。美國和加拿大的重播撥入號碼爲1-844-512-2921（免費電話），國際上爲1-412-317-6671（長途電話）。請使用重播密碼 13746549。
About Volition
關於 Volition
Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.
Volition 是一家跨國表觀遺傳學公司，專注於推進表觀遺傳學科學。Volition 致力於通過早期檢測、疾病和治療監測，拯救生命並改善患有改變生活的疾病的人和動物的預後。
Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential to not only prolong the life of patients, but also improve their quality of life.
Volition正在通過其子公司開發和商業化簡單、易於使用、具有成本效益的血液檢測，以幫助診斷和監測一系列疾病，包括一些癌症和與Netosis相關的疾病，例如敗血症。早期診斷和監測不僅有可能延長患者的壽命，而且有可能改善他們的生活質量。
Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.
Volition的研發活動集中在比利時，在美國設有創新實驗室和辦事處，在倫敦和新加坡設有辦事處。
The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.
在 Volition 的網站地址中找到的內容未以引用方式納入本文檔，因此不應視爲本文檔的一部分。此類網站地址僅作爲非活躍文本參考包含在本文檔中。
Media Enquiries:
媒體查詢：
Louise Batchelor/Debra Daglish, Volition, [email protected] +44 (0)7557 774620
Louise Batchelor/Debra Daglish，Volition，[email protected] +44 (0) 7557 774620
SOURCE VolitionRx Limited
來源 VolitionRX Limited
譯文內容由第三人軟體翻譯。